+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enzymes for Drug Synthesis Market - Global Forecast 2025-2030- Product Image
Enzymes for Drug Synthesis Market - Global Forecast 2025-2030- Product Image
Sale

Enzymes for Drug Synthesis Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6121950
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Enzyme-driven pharmaceutical synthesis is rapidly reshaping industry standards as manufacturers strive for greater efficiency, sustainability, and regulatory compliance. Market evolution is accelerating thanks to novel biocatalyst deployments, leading to advanced operational models and new supply chain strategies across global pharmaceutical networks.

Market Snapshot: Enzyme-Based Drug Synthesis

The global enzyme-based drug synthesis market demonstrates robust growth, marked by expanding adoption of biocatalysts and increasing demand for eco-friendly manufacturing. A diverse array of industry participants, from biotechnology start-ups to established pharmaceutical enterprises, are reconfiguring value chains to accommodate rising cost pressures and evolving environmental mandates. The market benefits from strong R&D pipeline investments and regulatory momentum favoring green chemistry initiatives, as organizations seek improved workflow efficiency and compliance with stringent standards.

Scope & Segmentation of the Enzyme-Based Drug Synthesis Market

This report provides a comprehensive analysis of the enzyme-enabled pharmaceutical manufacturing landscape, segmented by technology, application, source, process type, product form, end user, and region. Coverage reflects both current dynamics and future growth areas.

  • Enzyme Types: Hydrolase (including esterase, glycosidase, lipase, protease—such as aspartic, cysteine, metalloprotease, serine protease), isomerase, ligase, lyase, oxidoreductase (dehydrogenase, oxidase, oxygenase, reductase), transferase (aminotransferase, glycosyltransferase, methyltransferase, phosphotransferase).
  • Application Areas: Biocatalysis, chiral resolution, fermentation, precursor synthesis.
  • Sources: Animal, microbial, plant, and recombinant platforms (E. coli, fungal, yeast expression systems).
  • Process Types: Free enzyme, immobilized enzyme (carrier-bound, cross-linked).
  • Product Forms: Liquid and solid formulations.
  • End Users: Academic institutes, biotechnology companies, contract research organizations, pharmaceutical companies.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major European economies and select MENA countries), Asia-Pacific (China, India, Japan, Australia, and key Southeast Asian markets).
  • Key Companies: Novozymes A/S, Royal DSM N.V., DuPont de Nemours, BASF SE, Evonik Industries AG, Codexis Inc., AB Enzymes GmbH, Amano Enzyme Inc., Lonza Group AG, GenScript Biotech Corporation.

Key Takeaways for Decision-Makers

  • Enzyme application in drug synthesis provides reaction specificity and enhanced process efficiency, enabling cost-effective and leaner manufacturing models.
  • Advancements such as enzyme immobilization and biocatalyst recycling support continuous processing, which streamlines purification and reduces operational expenditure.
  • Synthetic biology and digital analytics are increasingly embedded into enzyme engineering, facilitating rapid variant design and more predictive manufacturing outcomes.
  • Regional trends reveal that North America, Europe, and Asia Pacific are driving innovation through strong public-private partnerships, targeted incentives, and harmonized regulatory standards.
  • Strategic collaborations and capacity expansions among leading companies are shaping market competition and improving supply chain resilience.
  • Customizable biocatalytic solutions empower both start-ups and multinational firms to meet complex regulatory and product development requirements.

Tariff Impact on Enzyme Sourcing & Supply Chains

Recent U.S. tariff changes have significantly influenced enzyme procurement and supply frameworks for drug manufacturers. Elevated costs from new import structures are prompting a realignment toward domestic production and diversified supplier engagement. Teams are partnering with regional providers and exploring onshore expression systems to mitigate risk, improve lead times, and reinforce material consistency. Industry associations are also working on policy advocacy, seeking exemptions and more streamlined customs for specialty enzymes.

Methodology & Data Sources

Research findings derive from in-depth interviews with enzyme engineers, supply chain strategists, and process scientists, complemented by secondary review of peer-reviewed literature, patents, regulatory guidelines, and industry white papers. Analytical rigor is ensured through cross-validated qualitative and quantitative assessments, with draft reviews by expert panels to authenticate insights.

Why This Report Matters

  • Gain actionable strategies for optimizing enzyme sourcing and integrating sustainable production practices.
  • Understand regulatory shifts and regional adoption patterns that affect execution of global drug development pipelines.
  • Benchmark against leading company initiatives and anticipate future technology, supply chain, and compliance trends.

Conclusion

Enzyme-based approaches are redefining drug synthesis, providing both operational and strategic value to forward-thinking organizations. This analysis equips industry executives with comprehensive insights to steer market-responsive, sustainable innovation across the pharmaceutical value chain.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in AI-driven enzyme engineering to accelerate novel biocatalyst discovery and optimization
5.2. Adoption of continuous flow chemoenzymatic cascade processes for efficient chiral drug intermediate synthesis
5.3. Development of thermostable and solvent-tolerant enzyme variants enabling high-temperature drug synthesis
5.4. Implementation of enzyme immobilization and recycling strategies to reduce production costs and waste
5.5. Utilization of genome mining and metagenomics to identify novel biocatalysts for complex pharmaceutical targets
5.6. Regulatory acceptance of biocatalytic methods driving shift from chemical to enzymatic pharmaceutical manufacturing
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Enzymes for Drug Synthesis Market, by Enzyme Type
8.1. Introduction
8.2. Hydrolase
8.2.1. Esterase
8.2.2. Glycosidase
8.2.3. Lipase
8.2.4. Protease
8.2.4.1. Aspartic Protease
8.2.4.2. Cysteine Protease
8.2.4.3. Metalloprotease
8.2.4.4. Serine Protease
8.3. Isomerase
8.4. Ligase
8.5. Lyase
8.6. Oxidoreductase
8.6.1. Dehydrogenase
8.6.2. Oxidase
8.6.3. Oxygenase
8.6.4. Reductase
8.7. Transferase
8.7.1. Aminotransferase
8.7.2. Glycosyltransferase
8.7.3. Methyltransferase
8.7.4. Phosphotransferase
9. Enzymes for Drug Synthesis Market, by Application
9.1. Introduction
9.2. Biocatalysis
9.3. Chiral Resolution
9.4. Fermentation
9.5. Precursor Synthesis
10. Enzymes for Drug Synthesis Market, by Source
10.1. Introduction
10.2. Animal
10.3. Microbial
10.4. Plant
10.5. Recombinant
10.5.1. E Coli Expression Systems
10.5.2. Fungal Expression Systems
10.5.3. Yeast Expression Systems
11. Enzymes for Drug Synthesis Market, by Process Type
11.1. Introduction
11.2. Free Enzyme
11.3. Immobilized Enzyme
11.3.1. Carrier Bound
11.3.2. Cross Linked
12. Enzymes for Drug Synthesis Market, by Product Form
12.1. Introduction
12.2. Liquid Form
12.3. Solid Form
13. Enzymes for Drug Synthesis Market, by End User
13.1. Introduction
13.2. Academic Institutes
13.3. Biotechnology Companies
13.4. Contract Research Organizations
13.5. Pharmaceutical Companies
14. Americas Enzymes for Drug Synthesis Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Enzymes for Drug Synthesis Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Enzymes for Drug Synthesis Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Novozymes a/S
17.3.2. Royal DSM N.V.
17.3.3. DuPont de Nemours, Inc.
17.3.4. BASF SE
17.3.5. Evonik Industries AG
17.3.6. Codexis, Inc.
17.3.7. AB Enzymes GmbH
17.3.8. Amano Enzyme Inc.
17.3.9. Lonza Group AG
17.3.10. GenScript Biotech Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ENZYMES FOR DRUG SYNTHESIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ENZYMES FOR DRUG SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ENZYMES FOR DRUG SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ENZYMES FOR DRUG SYNTHESIS MARKET: RESEARCHAI
FIGURE 28. ENZYMES FOR DRUG SYNTHESIS MARKET: RESEARCHSTATISTICS
FIGURE 29. ENZYMES FOR DRUG SYNTHESIS MARKET: RESEARCHCONTACTS
FIGURE 30. ENZYMES FOR DRUG SYNTHESIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ENZYMES FOR DRUG SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ESTERASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ESTERASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY GLYCOSIDASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY GLYCOSIDASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIPASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIPASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ASPARTIC PROTEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ASPARTIC PROTEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CYSTEINE PROTEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CYSTEINE PROTEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY METALLOPROTEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY METALLOPROTEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SERINE PROTEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SERINE PROTEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ISOMERASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ISOMERASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIGASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIGASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LYASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LYASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY DEHYDROGENASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY DEHYDROGENASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXYGENASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXYGENASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY REDUCTASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY REDUCTASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY AMINOTRANSFERASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY AMINOTRANSFERASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY GLYCOSYLTRANSFERASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY GLYCOSYLTRANSFERASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY METHYLTRANSFERASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY METHYLTRANSFERASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PHOSPHOTRANSFERASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PHOSPHOTRANSFERASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY BIOCATALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY BIOCATALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CHIRAL RESOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CHIRAL RESOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FERMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRECURSOR SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRECURSOR SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ANIMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ANIMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY MICROBIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY E COLI EXPRESSION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY E COLI EXPRESSION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FUNGAL EXPRESSION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FUNGAL EXPRESSION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FREE ENZYME, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FREE ENZYME, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CARRIER BOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CARRIER BOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CROSS LINKED, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CROSS LINKED, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIQUID FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOLID FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOLID FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 171. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2024 (USD MILLION)
TABLE 174. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2025-2030 (USD MILLION)
TABLE 175. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2024 (USD MILLION)
TABLE 176. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2025-2030 (USD MILLION)
TABLE 177. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2024 (USD MILLION)
TABLE 178. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2025-2030 (USD MILLION)
TABLE 179. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2024 (USD MILLION)
TABLE 180. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2025-2030 (USD MILLION)
TABLE 181. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 184. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 185. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 186. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 187. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 188. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 189. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2024 (USD MILLION)
TABLE 190. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2025-2030 (USD MILLION)
TABLE 191. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 192. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 193. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. CANADA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2024 (USD MILLION)
TABLE 196. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2025-2030 (USD MILLION)
TABLE 197. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2025-2030 (USD MILLION)
TABLE 199. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2024 (USD MILLION)
TABLE 200. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2025-2030 (USD MILLION)
TABLE 201. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2024 (USD MILLION)
TABLE 202. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2025-2030 (USD MILLION)
TABLE 203. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2024 (USD MILLION)
TABLE 204. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2025-2030 (USD MILLION)
TABLE 205. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 208. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 209. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 210. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 211. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 212. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2024 (USD MILLION)
TABLE 214. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2025-2030 (USD MILLION)
TABLE 215. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 216. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 217. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. MEXICO ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 315. UNIT

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Enzymes for Drug Synthesis market report include:
  • Novozymes A/S
  • Royal DSM N.V.
  • DuPont de Nemours, Inc.
  • BASF SE
  • Evonik Industries AG
  • Codexis, Inc.
  • AB Enzymes GmbH
  • Amano Enzyme Inc.
  • Lonza Group AG
  • GenScript Biotech Corporation

Related Topics

Related Reports

Enzymes for Antibiotic Synthesis Market - Global Forecast 2025-2030 - Product Image

Enzymes for Antibiotic Synthesis Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Diagnostic Enzymes Market - Global Forecast 2025-2030 - Product Image

Diagnostic Enzymes Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Hydrolase Enzymes Market Report 2025 - Product Image

Hydrolase Enzymes Market Report 2025

  • Report
  • 200 Pages
  • Global
From
DNases, Ligases, and RNA Polymerases - Global Strategic Business Report - Product Image

DNases, Ligases, and RNA Polymerases - Global Strategic Business Report

  • Report
  • 368 Pages
  • Global
From
Ligase Market - A Global and Regional Analysis: Focus on Product, Source, Application, End User, and Country - Analysis and Forecast, 2025-2035 - Product Image

Ligase Market - A Global and Regional Analysis: Focus on Product, Source, Application, End User, and Country - Analysis and Forecast, 2025-2035

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.